Retatrutide is a newly developed medication that acts as a strong GLP-1 receptor agonist. This innovative approach holds significant hope for managing type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide boosts insulin secretion and limits glucagon release, leading to improved glucose control. Clinical trials have demonstrated si